SEQUOIA trial: Zanubrutinib + venetoclax in treatment-naïve patients with CLL/SLL
During the European Hematology Association (EHA) 2024 Hybrid Congress, the Lymphoma Hub was pleased to speak to Paolo Ghia, Vita-Salute San Raffaele, Milan, IT. We asked about the latest updates from ...
12 Aug 20244min
SYMPHONY 1: A trial update
During the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Gilles Salles, Memorial Sloan Kettering Cancer Center, New York, US. We asked for an updat...
9 Jan 20235min
Novel therapies in chronic lymphocytic leukemia: An update.
During the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Chan Cheah, University of Western Australia, Perth, AU. We asked for an update on novel th...
5 Jan 20238min
What are the CAR T-cell therapies on the horizon for lymphoma?
During the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Pere Barba, Hospital Universitari Vall d'Hebron, Barcelona, ES. We asked, What are the chi...
3 Jan 20234min
How do you choose among different BTK inhibitors for treating CLL?
The Lymphoma Hub was pleased to speak with Francesc Bosch, Vall d’Hebron Barcelona Hospital Campus, Barcelona, ES. We asked, How do you choose among different BTK inhibitors for treating CLL?Bosch ope...
2 Des 20227min
What are the latest advances in basal PET/CT for Hodgkin and non-Hodgkin lymphoma?
The Lymphoma Hub was pleased to speak with Astrid Pavlovsky, FUNDALEU, Buenos Aires, AR. We asked, What are the latest advances in basal PET/CT for Hodgkin and non-Hodgkin lymphoma?Pavlovsky outlines ...
7 Nov 20229min
ASCT in DLBCL – is it over?
As part of our biannual steering committee meeting, Gilles Salles, Memorial Sloan Kettering Cancer Center, New York, USA, chaired a discussion session on the current and future role of autologous stem...
3 Aug 202217min
What is on the horizon for the frontline treatment of MCL?
During the ASCO2022 congress, the Lymphoma Hub was pleased to speak with Anita Kumar, Memorial Sloane Kettering Cancer Center, New York, US. We asked, What is on the horizon for the frontline treatmen...
25 Jul 20227min
